Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2004
Sansana Sawasdikosol, Ph.D.
The role of prostaglandin E2 and HPK1 in tumor-mediated immune suppression
Read More
2004
Loren D. Walensky, M.D., Ph.D.
Targeting cell death pathways in cancer using hydrocarbon-stapled helices
Read More
2004
Yong Wan, Ph.D.
Role of the ubiquitin-proteasome system in genomic integrity and tumor formation
Read More
2004
Michael L. Whitfield, Ph.D.
Genome-wide programs of cell growth and division
Read More
2003
Gerard C. Blobe, M.D., Ph.D.
Title identification of mechanisms for TGF-β Resistance and for the Dichotomous Function...
Read More
2003
Anjen Chenn, M.D., Ph.D.
Mechanisms of Beta Catenin in cancer and brain development
Read More
2003
Ramana Davuluri, Ph.D.
Computational approaches to explore transcriptional regulation in hematopoiesis and leukemia
Read More
2003
James DiRenzo, Ph.D.
Transcriptional control of multi-potency in mammary epithelia
Read More
2003
Lawrence Fong, M.D.
Induction and characterization of tumor-specific T cells in vivo
Read More
2003
Douglas K. Graham, M.D., Ph.D.
Use of transgenic mouse models to define a potential role of the...
Read More
2003
Prasad V. Jallepalli, M.D., Ph.D.
Targeting chromosomal instability for cancer therapy
Read More
2003
Deanna M. Koepp, Ph.D.
The Rote of SCF Ubiquitin Ligases in Cyclin E Proteolysis
Read More
2003
Shaoguang Li, M.D., Ph.D.
Genetic identification of key signaling molecules that have therapeutic potential for treating...
Read More
2003
Ben Ho Park, M.D., Ph.D.
Understanding BRCA-1 function by targeted gene disruption in a somatic normal breast...
Read More
2003
W. Kimryn Rathmell, M.D., Ph.D.
Functional effects of von Hippel-Lindau gene mutations in tumorigenesis
Read More
2003
Maria S. Soengas, Ph.D.
Inactivation of apoptosis in melanoma progression and drug resistance
Read More